Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Latin America Cancer Biomarkers Market: By Disease, By Type, By Profiling Technology, By Application and Geograpy
Latin America Cancer Biomarkers Market: By Disease, By Type, By Profiling Technology, By Application and Geograpy
Latin America Cancer Biomarkers Market size was valued at US$ x million in 2023 and is poised to grow at a CAGR of 10.9% from 2024 to 2030. The market report provides a detailed overview of the Latin America Cancer Biomarkers Market, which has been segmented by disease, type, filing technology, and application. By disease, the Latin American cancer biomarkers market has been segmented into In Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Other Diseases. The Breast Cancer segment is likely the largest and fastest-growing in terms of various disease types. The Latin American cancer biomarkers market has been segmented into Protein Biomarkers, Genetic Biomarkers, and Other Types. The Protein Biomarkers accounted for a significant revenue share in 2021. By profiling technology, the Latin American cancer biomarkers market has been segmented into OMICS Technology, Imaging Technology, Immunoassays, and Cytogenetics. OMICS Technology is expected to account for a significant revenue share from 2024 to 2030. Based on application, the Latin American cancer biomarkers are segmented into Diagnostics, Drug Discovery and Development, Prognostics, Risk Assessment, and Others. According to precision business insights, the Diagnostics segment is predicted to register the fastest growth rate during the forecast period.
Latin America Cancer Biomarkers Market Key Development:
In November 2020, Agilent Technologies Inc. launched the Biomarker Pathologist Training Program, a global initiative designed to help pathologists precisely score biomarkers.
Study Period
2024-2030Base Year
2023CAGR
10.9%Largest Market
N/AFastest Growing Market
N/A
The importance of biological and targeted medicinal therapies, as well as the accuracy, dependability, and technological developments of cancer biomarkers, are expected to drive the growth of the cancer biomarkers market.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market CAGR |
10.9% |
|
By Disease |
|
|
By Type |
|
|
By Application |
|
Download Free Sample Report
The Latin America Cancer Biomarkers Market size was valued at US$ x million in 2023
The Latin America Cancer Biomarkers Market Report data: (Latin America, Brazil, Mexico, Rest of LA)
The Latin America Cancer Biomarkers Market key players are: Thermo Fisher Scientific Bio-Rad Laboratories Roche Diagnostics Qiagen N.V. Illumina GE Healthcare Agilent Technologies Biomrieux SA Merck & Co. Abbott Laboratories Becton, Dickinson and Company
| 1. Executive Summary |
| 2. Latin America Cancer Biomarkers Market Introduction |
| 2.1. Latin America Cancer Biomarkers Market Taxonomy |
| 2.2. Latin America Cancer Biomarkers Market Definitions |
| 2.2.1. Disease |
| 2.2.2. Type |
| 2.2.3. Profiling Technology |
| 2.2.4. Application |
| 3. Latin America Cancer Biomarkers Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Latin America Cancer Biomarkers Market Dynamic Factors - Impact Analysis |
| 3.6. Latin America Cancer Biomarkers Market Competition Landscape |
| 4. Latin America Cancer Biomarkers Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Latin America Cancer Biomarkers Market, By Disease, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1. Prostate Cancer |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Breast Cancer |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Lung Cancer |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Colorectal Cancer |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Cervical Cancer |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Other Diseases |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6. Latin America Cancer Biomarkers Market Forecast, By Type, 2019 - 2023 and Forecast, 2020 2026 (Revenue, USD Mn) |
| 6.1. Protein Biomarkers |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Genetic Biomarkers |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Other Types |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Latin America Cancer Biomarkers Market Forecast, By Profiling Technology, 2019 - 2023 and Forecast, 2020 2026 (Revenue, USD Mn) |
| 7.1. OMICS Technology |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Imaging Technology |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Immunoassays |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Cytogenetics |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Latin America Cancer Biomarkers Market Forecast, By Application, 2019 - 2023 and Forecast, 2024 - 2030 |
| 8.1. Diagnostics |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Drug Discovery and Development |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Prognostics |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Risk Assessment |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Others |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. Latin America Cancer Biomarkers Market Forecast, By Country, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.1. Brazil |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Mexico |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Argentina |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Rest of Latin America |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America Cancer Biomarkers Market - Opportunity Analysis Index, By Disease, Type, Profiling Technology, Application and Country, 2024 - 2030 |
| 10. Latin America Cancer Biomarkers Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 10.1. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Prostate Cancer |
| 10.1.2. Breast Cancer |
| 10.1.3. Lung Cancer |
| 10.1.4. Colorectal Cancer |
| 10.1.5. Cervical Cancer |
| 10.1.6. Other Diseases |
| 10.2. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Protein Biomarkers |
| 10.2.2. Genetic Biomarkers |
| 10.2.3. Other Types |
| 10.3. Profiling Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. OMICS Technology |
| 10.3.2. Imaging Technology |
| 10.3.3. Immunoassays |
| 10.3.4. Cytogenetics |
| 10.4. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Diagnostics |
| 10.4.2. Drug Discovery and Development |
| 10.4.3. Prognostics |
| 10.4.4. Risk Assessment |
| 10.4.5. Others |
| 10.5. Latin America Cancer Biomarkers Market - Opportunity Analysis Index, By Disease, Type, Profiling Technology, Application and Country, 2024 - 2030 |
| 10.6. Latin America Cancer Biomarkers Market Dynamics Trends |
| 11. Latin America Cancer Biomarkers Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 11.1. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Prostate Cancer |
| 11.1.2. Breast Cancer |
| 11.1.3. Lung Cancer |
| 11.1.4. Colorectal Cancer |
| 11.1.5. Cervical Cancer |
| 11.1.6. Other Diseases |
| 11.2. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Protein Biomarkers |
| 11.2.2. Genetic Biomarkers |
| 11.2.3. Other Types |
| 11.3. Profiling Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. OMICS Technology |
| 11.3.2. Imaging Technology |
| 11.3.3. Immunoassays |
| 11.3.4. Cytogenetics |
| 11.4. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Diagnostics |
| 11.4.2. Drug Discovery and Development |
| 11.4.3. Prognostics |
| 11.4.4. Risk Assessment |
| 11.4.5. Others |
| 11.5. Latin America Cancer Biomarkers Market - Opportunity Analysis Index, By Disease, Type, Profiling Technology, Application and Country, 2024 - 2030 |
| 11.6. Latin America Cancer Biomarkers Market Dynamics Trends |
| 12. Latin America Cancer Biomarkers Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 12.1. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Prostate Cancer |
| 12.1.2. Breast Cancer |
| 12.1.3. Lung Cancer |
| 12.1.4. Colorectal Cancer |
| 12.1.5. Cervical Cancer |
| 12.1.6. Other Diseases |
| 12.2. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Protein Biomarkers |
| 12.2.2. Genetic Biomarkers |
| 12.2.3. Other Types |
| 12.3. Profiling Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. OMICS Technology |
| 12.3.2. Imaging Technology |
| 12.3.3. Immunoassays |
| 12.3.4. Cytogenetics |
| 12.4. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Diagnostics |
| 12.4.2. Drug Discovery and Development |
| 12.4.3. Prognostics |
| 12.4.4. Risk Assessment |
| 12.4.5. Others |
| 12.5. Latin America Cancer Biomarkers Market - Opportunity Analysis Index, By Disease, Type, Profiling Technology, Application and Country, 2024 - 2030 |
| 12.6. Latin America Cancer Biomarkers Market Dynamics Trends |
| 13. Latin America Cancer Biomarkers Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 13.1. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Prostate Cancer |
| 13.1.2. Breast Cancer |
| 13.1.3. Lung Cancer |
| 13.1.4. Colorectal Cancer |
| 13.1.5. Cervical Cancer |
| 13.1.6. Other Diseases |
| 13.2. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.2.1. Protein Biomarkers |
| 13.2.2. Genetic Biomarkers |
| 13.2.3. Other Types |
| 13.3. Profiling Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. OMICS Technology |
| 13.3.2. Imaging Technology |
| 13.3.3. Immunoassays |
| 13.3.4. Cytogenetics |
| 13.4. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Diagnostics |
| 13.4.2. Drug Discovery and Development |
| 13.4.3. Prognostics |
| 13.4.4. Risk Assessment |
| 13.4.5. Others |
| 13.5. Latin America Cancer Biomarkers Market - Opportunity Analysis Index, By Disease, Type, Profiling Technology, Application and Country, 2024 - 2030 |
| 13.6. Latin America Cancer Biomarkers Market Dynamics Trends |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.2. Company Profiles (Introduction, Financial Analysis, Disease & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 14.2.1. Thermo Fisher Scientific |
| 14.2.2. Bio-Rad Laboratories |
| 14.2.3. Roche Diagnostics |
| 14.2.4. Qiagen N.V. |
| 14.2.5. Illumina |
| 14.2.6. GE Healthcare |
| 14.2.7. Agilent Technologies |
| 14.2.8. Biomérieux SA |
| 14.2.9. Merck & Co. |
| 14.2.10. Abbott Laboratories |
| 14.2.11. Becton, Dickinson and Company |
| 14.2.12. Quest Diagnostics |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.